Temporal effects of antibiotic use and Clostridium difficile infections. (Q45905111)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19372170%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Temporal effects of antibiotic use and Clostridium difficile infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19372170%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

main subject

Clostridium difficile

0 references

author

Nathalie Vernaz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19372170%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Kirsteen Hill

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19372170%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Stephanie Leggeat

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19372170%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Dilip Nathwani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19372170%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Gabby Philips

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19372170%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Pascal Bonnabry

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19372170%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Peter Davey

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19372170%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

English

0 references

publication date

16 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19372170%20AND%20SRC:MED&resulttype=core&format=json

Journal of Antimicrobial Chemotherapy

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19372170%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19372170%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19372170%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

1272-1275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19372170%20AND%20SRC:MED&resulttype=core&format=json

Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP128

Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow Antimicrobial Audit Tool (GAAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP128

Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP128

Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP128

Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP128

Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP128

Antimicrobial-associated risk factors for Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP128

Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP128

Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP128